Editorial: FroM Amrita to Substance D: Psychopharmacology, Political Economy, and Technologies of the Self

Transcultural Psychiatry

Volumn 46, Issue 1, 2009, Pages 5-15

  Kirmayer, Laurence J ^a   Raikhel, Eugene ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

BRAIN; COMPARATIVE STUDY; CULTURAL FACTOR; DRUG EFFECT; DRUG INDUSTRY; ECONOMICS; EDITORIAL; EGO; ETHICS; HISTORY; HUMAN; MARKETING; MEDICAL ETHICS; MENTAL DISEASE; POLITICS; RELIGION; SOCIAL PROBLEM; SOCIAL PSYCHOLOGY; SYMBOLISM;

ALCHEMY; BRAIN; CEREMONIAL BEHAVIOR; CROSS-CULTURAL COMPARISON; DRUG INDUSTRY; EGO; ETHICS, MEDICAL; ETHICS, PHARMACY; HALLUCINOGENS; HUMANS; MARKETING; MENTAL DISORDERS; PLANT EXTRACTS; POLITICS; PSYCHOTROPIC DRUGS; SOCIAL PROBLEMS; SOCIAL VALUES; SPIRITUALITY;

EID: 63049097292     PISSN: 13634615     EISSN: None     Source Type: Journal    
DOI: 10.1177/1363461509102284     Document Type: Editorial

References (31)

1. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
2. Applbaum, K. (2006). Pharmaceutical marketing and the invention of the medical consumer. PLoS Medicine, 3(4), e189.
3. Birnbaum, R. (1989). The healing Buddha. Boston: Shambhala.
4. Dick, P.K. (1977). A scanner darkly. Garden City, NY: Doubleday.
5. Dyck, E. (2006). Prairie psychedelics: Mental health research in Saskatchewan, 1951-1967. In J. E. Moran & D. Wright (Eds.), Mental health and Canadian society (pp. 221–244). Montreal & Kingston: McGill-Queen's University Press.
6. Fisher, H.E., & Thomson, J.A., Jr. (2006). Lust, romance, attachment: Do the side-effects of serotonin-enhancing antidepressants jeopardize romantic love, marriage, and fertility? In S. M. Platek, J. P. Keenan, & T. K. Shackelford (Eds.), Evolutionary cognitive neuroscience (pp. 245–284). Cambridge, MA: MIT Press.
7. Furst, P.T. (1976). Hallucinogens and culture. San Francisco: Chandler & Sharp.
8. Griffiths, R.R., Richards, W.A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl), 187(3), 268-283; discussion 284-292.
9. Hajicek-Dobberstein, S. (1995). Soma siddhas and alchemical enlightenment: psychedelic mushrooms in Buddhist tradition. Journal of Ethnopharmacology, 48(2), 99-118.
10. Healy, D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press.
11. Healy, D. (2004). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press.
12. Horwitz, A.V., & Wakefield, J.C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
13. Huxley, A. (1962). Island, a novel. New York: Harper.
14. Huxley, A. (1963). The doors of perception, and heaven and hell. New York: Harper & Row.
15. Huxley, A., Horowitz, M., & Palmer, C. (1999). Moksha: Aldous Huxley's classic writings on psychedelics and the visionary experience. Rochester, VT: Park Street Press.
16. Huxley, L.A. (1968). This timeless moment: A personal view of Aldous Huxley. New York: Farrar.
17. Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., & Johnson, B.T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), e45.
18. Kramer, P. (1993). Listening to Prozac. New York: Viking.
19. Klüver, H. (1966). Mescal, and mechanisms of hallucinations. Chicago: University of Chicago Press.
20. Kripal, J.J. (2006). Reality against society: William Blake, Antinomianism and the American counterculture. Common Knowledge, 13(1), 98-112.
21. Mandell, A.J. (1973). Neurobiological barriers to euphoria. American Scientist, 61(5), 565-573.
22. Naranjo, C. (1974). The healing journey: New approaches to consciousness. New York: Pantheon Books.
23. Nichols, D.E. (2004). Hallucinogens. Pharmacology & Therapeutics, 101(2), 131-181.
24. Rose, N. (2003). Neurochemical selves. Society, 41(1), 49-59.
25. Rose, N. (2004). Becoming neurochemical selves. In N. Stehr (Ed.), Biotechnology, commerce and civil society (pp. 89–128). New York: Transaction Press.
26. Smith, H. (1964). Do drugs have religious import? Journal of Philosophy, 61(18), 517-530.
27. Smith, H. (2000). Cleansing the doors of perception: The religious significance of entheogenic plants and chemicals. New York: Jeremy P. Tarcher/Putnam.
28. Wakefield, J.C., Schmitz, M.F., First, M.B., & Horwitz, A.V. (2007). Extending the bereavement exclusion for major depression to other losses: Evidence from the National Comorbidity Survey. Archives of General Psychiatry, 64(4), 433-440.
29. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283(3), 373-380.
30. Wazana, A., & Primeau, F. (2002). Ethical considerations in the relationship between physicians and the pharmaceutical industry. Psychiatric Clinics of North America, 25(3), 647-663.
31. Youngquist, P. (2000). Score, scan, schiz: Dick on drugs. Cultural Critique, 44, 84-110.